Chemotherapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chemotherapy stocks.

Chemotherapy Stocks Recent News

Date Stock Title
May 15 CLRB Q1 2024 Cellectar Biosciences Inc Earnings Call
May 15 CLRB Cellectar Biosciences Inc (CLRB) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 CADL Candel Therapeutics GAAP EPS of -$0.28
May 14 CLRB Cellectar Biosciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 14 CLRB Cellectar Biosciences, Inc. (CLRB) Q1 2024 Earnings Call Transcript
May 14 CADL Candel Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Recent Corporate Highlights
May 14 ALKS Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
May 14 CLRB Cellectar Biosciences GAAP EPS of -$0.74 misses by $0.18
May 14 CLRB Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
May 13 CRDF Cardiff Oncology to Present at Upcoming Investor Conferences in May
May 13 CLRB Cellectar Biosciences Q1 2024 Earnings Preview
May 13 BNTC Benitec GAAP EPS of -$1.64
May 13 CKPT Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13 BNTC Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
May 12 CKPT Checkpoint Therapeutics First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.89 loss in 1Q 2023)
May 11 CHRS Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 10 CHRS Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2024 Earnings Call Transcript
May 10 CKPT Checkpoint Therapeutics GAAP EPS of -$0.33
May 10 CKPT Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 10 CHRS Coherus BioSciences, Inc. (CHRS) Q1 2024 Earnings Call Transcript
Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

Browse All Tags